- 专利标题： METHODS FOR DEVELOPING PERSONALIZED DRUG TREATMENT PLANS AND TARGETED DRUG DEVELOPMENT BASED ON PROTEOMIC PROFILES
-
申请号： EP16775898.6申请日： 2016-09-09
-
公开(公告)号： EP3347720A1公开(公告)日： 2018-07-18
- 发明人: GOLD, Larry , DELISLE, Robert Kirk , STERLING, David , OSTROFF, Rachel , ZICHI, Dom
- 申请人： Somalogic, Inc.
- 申请人地址： 2945 Wilderness Place Boulder, CO 80301 US
- 专利权人： Somalogic, Inc.
- 当前专利权人： Somalogic, Inc.
- 当前专利权人地址： 2945 Wilderness Place Boulder, CO 80301 US
- 代理机构： Clegg, Richard Ian
- 优先权： US201562215852P 20150909
- 国际公布： WO2017044715 20170316
- 主分类号： G01N33/68
- IPC分类号： G01N33/68
摘要：
The present invention relates to developing customized therapies for a disease or condition in a subject. In particular, the present invention relates to aptamer-based compositions and methods for identifying, modulating and monitoring drug targets in individual with a disease or condition, and further composition and methods for identifying and selecting protein targets for drug development.
信息查询
IPC分类:
